Birmingham biotech company receives $1.2M toward research


A Birmingham biotech company has received over a million dollars in funding toward research to treat a chronic kidney disease.

Previous Sen. Warren asks feds to halt $13.4B TD-First Horizon deal over customer abuse allegations about TD
Next Women of Influence 2022: Jennifer Ernst of Tivic Health